A comparative analysis of EGFR and IGFIR pathways in lung cancer using optimization methods /

A comparative analysis of EGFR and IGFIR pathways in lung cancer using optimization methods /

Show other versions (1)

Project Paper (Sarjana Muda Sains Komputer (Bioinformatik)) - Universiti Teknologi Malaysia, 2014

Bibliographic Details
Main Authors:	Noor Hidayah Mohideen, 1991-, author 604990, Afnizanfaizal Abdullah, 1985-, supervisor 485493, Fakulti Komputeran 538688
Format:
Language:	eng
Published:	Johor Bahru, Johor : Universiti Teknologi Malaysia, 2014
Subjects:	Lungs Computational biology

Similar Items

A comparative analysis of EGFR and IGFIR pathways in lung cancer using optimization methods /
by: Noor Hidayah Mohideen, 1991-, author 604990
Published: (2014)

Limiting and excreting metabolites of succinate production in s.cerevisiae using flux balance analysis /
by: Nurhafiza Rosdi, 1991-, author 604985, et al.
Published: (2014)

New hyper-heuristic algorithm for gene fragment assembly /
by: Murniyanti Malik, 1991-, author 604951, et al.
Published: (2017)

Classification of DNA sequences using deep convolutional neural network /
by: Nurul Amerah Kassim, 1994-, author 611734, et al.
Published: (2017)

Comparing the Efficacy of Two Generations of EGFR-TKIs: An Integrated Drug–Disease Mechanistic Model Approach in EGFR-Mutated Lung Adenocarcinoma
by: Hippolyte Darré, et al.
Published: (2024-03-01)

Characterizing the secretome of EGFR mutant lung adenocarcinoma
by: Jennifer K. Luu, et al.
Published: (2024-01-01)

Parameter estimation of microbial models using hybrid optimization methods [electronic resource] /
by: Afnizanfaizal Abdullah, 1985-
Published: (2013)

Optimal intervention timing for craniocerebral radiotherapy in EGFR mutant lung adenocarcinoma patients with brain metastases
by: Guangchuan Deng, et al.
Published: (2024-12-01)

Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing
by: Nahar, Rahul, et al.
Published: (2018)

Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling.
by: Gao, S, et al.
Published: (2014)

EGFR amplification indicated poor prognosis in EGFR‐mutated lung cancer with leptomeningeal metastases
by: Di Geng, et al.
Published: (2024-02-01)

Parameter estimation of microbial models using hybrid optimization methods /
by: Afnizanfaizal Abdullah, 1985-, author, et al.
Published: (2013)

Gene essentiality and nutrient rescue prediction using limed-fba in neurospora crassa /
by: Goh, Melanie Ai Ping, 1990-, author, et al.
Published: (2014)

Improved amortized time and optimality of pathfinding algorithm for inferring relevant pathways in metabolic network /
by: Zeyad Abd Algfoor Hasan 1982-, author 656579, et al.
Published: (2017)

Pitavastatin sensitizes the EGFR-TKI associated resistance in lung cancer by inhibiting YAP/AKT/BAD-BCL-2 pathway
by: Jie Liu, et al.
Published: (2024-06-01)

The prognosis of TP53 and EGFR co-mutation in patients with advanced lung adenocarcinoma and intracranial metastasis treated with EGFR-TKIs
by: Weiguo Gu, et al.
Published: (2024-02-01)

Prognostic and predictive value of interstitial lung abnormalities and EGFR mutation status in patients with non-small cell lung cancer
by: Xiaoli Xu, et al.
Published: (2024-05-01)

STK11 genetic alterations in metastatic EGFR mutant lung cancer
by: Dandan Yin, et al.
Published: (2025-02-01)

Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR Mutation
by: Chang Dong Yeo, et al.
Published: (2025-01-01)

Distinction of ALK fusion gene‐ and EGFR mutation‐positive lung cancer with tumor markers
by: Takahiro Akita, et al.
Published: (2024-04-01)

ALK-rearranged and EGFR wild-type lung adenocarcinoma transformed to small cell lung cancer: a case report
by: Rui Chen, et al.
Published: (2024-04-01)

Profiling of driver mutations in lung adenocarcinoma patients identifies rare compound EGFR mutations sensitive to second-generation EGFR-TKIs
by: Jun Li, et al.
Published: (2024-12-01)

A comparative study between flux balance analysis and kinetic model for C. acetobutylicum /
by: Murniyanti Malik, 1991-, author, et al.
Published: (2014)

Exploratory analysis of immunochemotherapy compared to chemotherapy after EGFR‐TKI in non–small cell lung cancer patients with EGFR mutation: A multicenter retrospective study
by: Tae Hata, et al.
Published: (2023-04-01)

Investigation of RBM10 mutation and its associations with clinical and molecular characteristics in EGFR-mutant and EGFR-wildtype lung adenocarcinoma
by: Yingyue Cao, et al.
Published: (2024-06-01)

Dihydroartemisinin-driven selective anti-lung cancer proliferation by binding to EGFR and inhibition of NRAS signaling pathway-induced DNA damage
by: Liu-Gen Li, et al.
Published: (2024-05-01)

A Case Report of EGFR-TKIs Resistant Secondary MET Gene Amplified  Lung Squamous Cell Carcinoma and Literature Review
by: Yalan LIU, et al.
Published: (2024-11-01)

Detection of EGFR gene mutations for prescription of targeted drugs for non-small cell lung cancer
by: O. N. Pavlova, et al.
Published: (2024-04-01)

CCL2 promotes EGFR-TKIs resistance in non-small cell lung cancer via the AKT-EMT pathway
by: Diao Yunlian, et al.
Published: (2024-07-01)

Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI
by: Jianghua Ding, et al.
Published: (2024-02-01)

Targeting the Tumor Microenvironment in EGFR-Mutant Lung Cancer: Opportunities and Challenges
by: Jeong Uk Lim, et al.
Published: (2025-02-01)

Deciphering the Dynamics of EGFR-TKI Resistance in Lung Cancer: Insights from Bibliometric Analysis
by: Zhou Y, et al.
Published: (2024-09-01)

Adequacy of biopsy samples for epidermal growth factor receptor (EGFR) molecular testing in lung adenocarcinoma
by: Tegeltija Dragana, et al.
Published: (2021-01-01)

Biomarkers of Acute Lung Lesion
by: Ye. V. Grigoryev, et al.
Published: (2006-08-01)

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma
by: Verma, Akash, et al.
Published: (2017)

Targeting EGFR signalling pathway in triple negative breast cancer
by: Albukhari, A
Published: (2014)

Targeting EGFR signalling pathway in triple negative breast cancer
by: Albukhari, A
Published: (2014)

Progress of Immunotherapy in EGFR-mutated Advanced Non-small Cell Lung Cancer
by: Yaoyao LIU, et al.
Published: (2023-12-01)

Case report: EGFR fusion mutation combined with EGFR amplification responds to EGFR-TKI therapy
by: Zhulin Wang, et al.
Published: (2024-03-01)

Targeting Transient Receptor Potential Melastatin‐2 (TRPM2) Enhances Therapeutic Efficacy of Third Generation EGFR Inhibitors against EGFR Mutant Lung Cancer
by: Zhen Chen, et al.
Published: (2024-09-01)